Semaglutide confers similar weight, cardiovascular benefits across all menopausal stages

Once-weekly injectable semaglutide is tied to weight loss and cardiovascular benefits for women regardless of menopause status, according to data from two post hoc analyses presented at the European Congress on Obesity.“Menopause is more than hot flushes; it’s a cardiometabolic transition,” Emilia Huvinen, MD, PhD, associate professor and specialist in obstetrics and gynecology